Skip to main content

Table 2 Comparison of the mRNA expression of MMP9 among the treatment groups x ¯ ± SD

From: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer

Group

n

MMP9 mRNA

 

DMSO

10

1.320 ± 0.0524

 

CoCl2

10

0.881 ± 0.0723

 

glibenclamide

10

0.941 ± 0.0948

F = 447.86 P = 0.021

CoCl2 + glibenclamide

10

0.481 ± 0.0685

 

paclitaxel

10

0.424 ± 0.0517

Â